Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/07/2012WO2012072512A1 N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists
06/07/2012WO2012072505A1 Volasertib alone or in combination with cytarabine for treating acute myeloid leukemia
06/07/2012WO2012072374A1 Priming solutions for cardiopulmonary bypass
06/07/2012WO2012072256A2 Once daily formulation of lacosamide
06/07/2012WO2012072200A1 3-hetaryl-substituted pyrrolo[2,3-b]pyridine derivatives as pdk1 inhibitors
06/07/2012WO2012072055A1 Use of pacap for treating viral infections in aquatic organisms
06/07/2012WO2012072033A1 Substituted 2,3-phthalazinone compounds and use thereof
06/07/2012WO2012072019A1 Targeting human thymidylate kinase induces dna repair toxicity in malignant tumor cells
06/07/2012WO2012072014A1 Transdermal patch preventing volatilization of rasagiline
06/07/2012WO2012071706A1 Pharmaceutical composition for preventing and treating diabetes and its complications
06/07/2012WO2012071684A1 Heterocyclic derivates，preparation processes and medical uses thereof
06/07/2012WO2012071612A1 Treatment of jak2-mediated conditions
06/07/2012WO2012071611A1 Histone inhibition
06/07/2012WO2012054831A3 Ready to use ketorolac formulations
06/07/2012WO2012054718A9 Treating long qt syndrome
06/07/2012WO2012047856A3 Novel inhibitors of secretion of hepatitis b virus antigens
06/07/2012WO2012046145A3 Coriolus versicolor extracts, methods of preparation and uses thereof
06/07/2012WO2012044046A3 Novel methylcyclohexane derivatives and uses thereof
06/07/2012WO2012040641A3 Compounds for treating neurodegenerative diseases
06/07/2012WO2012040258A3 Therapeutic piperazines
06/07/2012WO2012037912A3 Use of corrinoids for pharmaceutical application in the event of coat and skin disorders in small and large animals (warm- and cold-blooded) {for example in fish, birds, horses, cattle, camels, dogs, cats, reptiles}
06/07/2012WO2012037508A3 Antibacterial agents: high-potency myxopyronin derivatives
06/07/2012WO2012037261A3 6-substituted demethyl-estradiol derivatives as er-beta agonists
06/07/2012WO2012037187A3 Preparation of crystalline bazedoxifene and its salts
06/07/2012WO2012036523A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
06/07/2012WO2012036518A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
06/07/2012WO2012036507A3 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof
06/07/2012WO2012035478A3 Antifungal varnish composition
06/07/2012WO2012033983A3 Candesartan pharmaceutical compositions
06/07/2012WO2012033792A3 Treatment of diseases
06/07/2012WO2012033353A9 Sesterterpene compounds and use thereof
06/07/2012WO2012030685A3 Indazole derivatives useful as erk inhibitors
06/07/2012WO2012028310A3 Compositions comprising a taxane for coating medical devices
06/07/2012WO2012027462A3 Compositions and methods for treating neoplasia
06/07/2012WO2012026766A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2012026765A3 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
06/07/2012WO2012021133A9 Synthetic bile acid compositions and methods
06/07/2012WO2012020123A9 Neuropilin as a biomarker for bevacizumab combination therapies
06/07/2012WO2012019106A3 Compounds for use in modulating the nmda receptor
06/07/2012WO2012015944A8 Novel tetrahydronaphtalene antagonists to the thromboxane a2 (tp) receptor
06/07/2012WO2012014052A3 Novel coated extended release pharmaceutical compositions containing paliperidone
06/07/2012WO2012010120A3 Use of corrinoids for cosmetic application in the case of healthy coats and/or healthy skin, and for cosmetic care in the case of coat and skin illnesses for small and large animals (warm- and cold-blooded) {for example, for fish, birds, horses, cows, camels, dogs, cats, reptiles}
06/07/2012WO2012004258A9 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
06/07/2012WO2011163458A3 Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations
06/07/2012WO2011160821A3 Organic salts and co-crystals of phenylbutyric acid
06/07/2012WO2011157722A3 Solid ivabradine-containing composition
06/07/2012WO2011157721A3 Ivabradine-containing pharmaceutical composition
06/07/2012WO2011157416A3 Transdermal administration of memantine
06/07/2012WO2011156003A3 Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
06/07/2012WO2011150239A3 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
06/07/2012WO2011147536A3 Topical pharmaceutical compositions comprising mometasone furoate
06/07/2012WO2011146808A3 Topical formulation for a jak inhibitor
06/07/2012WO2011132075A3 A hydrate of a cyclohexanamine derivative
06/07/2012WO2011117333A3 Reverse micelle microemulsion comprising metal ions and use thereof
06/07/2012WO2011023986A8 Kinase inhibitors
06/07/2012US20120144511 Muteins of the pyrroline-5-carboxylate reductase 1
06/07/2012US20120144510 Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
06/07/2012US20120144504 Caspase-8 and skin disease
06/07/2012US20120142786 Oregano extract for alertness
06/07/2012US20120142785 Methods for treating alzheimer's disease
06/07/2012US20120142784 Lysine-specific demethylase 1(lsd1) is a biomarker for breast cancer
06/07/2012US20120142783 Enhanced bimatoprost ophthalmic solution
06/07/2012US20120142782 Enhanced cimatoprost ophthalmic solution
06/07/2012US20120142781 Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States
06/07/2012US20120142780 Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases
06/07/2012US20120142779 Stable injectable compositions
06/07/2012US20120142778 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids
06/07/2012US20120142777 Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
06/07/2012US20120142776 Methods and compositions for inducing physiological hypertrophy
06/07/2012US20120142775 Treatment of neurodegenerative conditions
06/07/2012US20120142774 Emulsifying preparation
06/07/2012US20120142773 Use of pufas for treating skin inflammation
06/07/2012US20120142772 Benzo Lipoxin Analogues
06/07/2012US20120142771 Biphenylacetamide derivative
06/07/2012US20120142770 Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
06/07/2012US20120142769 Methods for treating or preventing fatigue
06/07/2012US20120142768 Formulations including amiodarone and salts thereof and methods of their manufacture and use
06/07/2012US20120142766 Substituted 1,3-dioxanes and their uses
06/07/2012US20120142765 Sphingosine-bound siRNA
06/07/2012US20120142764 Multi-Cistronic shRNA Expression Cassette for Suppressing Single or Multiple Target Genes
06/07/2012US20120142763 Nucleic acid delivery compositions and methods of use thereof
06/07/2012US20120142762 Method for Preventing and Treating Cardiovascular Diseases with BRCA1
06/07/2012US20120142761 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142759 Soluble thf receptors and their use in treatment of disease
06/07/2012US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
06/07/2012US20120142757 RNAi Modulation of AHA and Therapeutic Uses Thereof
06/07/2012US20120142755 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation
06/07/2012US20120142754 Modulation of timp1 and timp2 expression
06/07/2012US20120142753 Diagnosis and treatment of adrenocortical tumors using human microrna-483
06/07/2012US20120142752 Hiv protease inhibitors
06/07/2012US20120142751 Methods for the production of biliverdin
06/07/2012US20120142750 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
06/07/2012US20120142749 Solid salt forms of a pyrrole substituted 2-indolinone
06/07/2012US20120142748 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
06/07/2012US20120142747 Compositions and methods for delivering clonidine to a target tissue site
06/07/2012US20120142746 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
06/07/2012US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142743 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
1 ... 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 ... 7860